I am a physician-scientist who focuses on the development of new multimodal imaging approaches for specific applications, such as sequential in vivo imaging studies in cancer biology, cancer immunotherapy, and radiation sciences.
Read more Read less
The goal of my research is to investigate the role of dynamic gene expression imaging in tumor biology and therapy using noninvasive imaging. Specifically, my studies focus on imaging the activity of key signaling pathways involved in tumor proliferation and function influenced by tumor microenvironment. My primary aim is to develop widely applicable methods for in vivo, noninvasive monitoring of molecular-biological processes in cancer-specific cell therapies and to monitor their efficacy using multimodality molecular imaging approaches, including optical, magnetic resonance, and nuclear techniques.
My research aims to develop (a) new approaches for repetitive in vivo optical, nuclear, and magnetic resonance imaging of the fate of cancer-specific immune cells after their adoptive transfer for antitumor immunotherapy (conducted initially in animals and then in patients); (b) novel assessments of targeted drug therapies based on imaging of specific signal transduction pathways pre- and post-treatment, with the goal of rapid translation into relevant clinical studies; and (c) new multimodal genetic reporter systems for different imaging technologies to be combined during the course of the same study and in a way that harnesses the best features and utilities of each of the modalities.
- Clinical Expertise: Cancer Therapeutics & Drug Development; Immunology; Molecular Imaging
- Languages Spoken: English
- Education: MD, State Medical University of Russia (Moscow); PhD, Institute of Pediatric Hematology of Russia (Moscow)
- Residencies: Institute of Pediatric Hematology of Russia and Pediatric Hospital of Russia (Moscow)
- Fellowships: Children's National Medical Center (Washington, DC); Memorial Sloan Kettering Cancer Center
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more